A carregar...
Reliever salbutamol use as a measure of exacerbation risk in chronic obstructive pulmonary disease
BACKGROUND: Debate exists regarding which endpoints most sensitively reflect day-to-day variation in chronic obstructive pulmonary disease (COPD) symptoms and are most useful in clinical practice to predict COPD exacerbations. We hypothesized that short-acting β(2)-agonist (SABA) reliever use would...
Na minha lista:
| Publicado no: | BMC Pulm Med |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4546184/ https://ncbi.nlm.nih.gov/pubmed/26293575 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12890-015-0077-0 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|